Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Single Nucleotide Polymorphism of Genes Associated with Metabolic Fatty Liver Disease
Tong Mu, Linrui Peng, Xinglei Xie, et al.
Journal of Oncology (2022) Vol. 2022, pp. 1-6
Open Access | Times Cited: 10

Showing 10 citing articles:

Metabolic-Dysfunction-Associated Fatty Liver Disease and Gut Microbiota: From Fatty Liver to Dysmetabolic Syndrome
Ludovico Abenavoli, Giuseppe Guido Maria Scarlata, Emidio Scarpellini, et al.
Medicina (2023) Vol. 59, Iss. 3, pp. 594-594
Open Access | Times Cited: 28
Genome-wide association study of metabolic dysfunction-associated fatty liver disease in a Korean population
Young Lee, Eun Ju Cho, Eun Kyung Choe, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 5
Liver Biopsy Handling of Metabolic-Associated Fatty Liver Disease (MAFLD): the Children’s Hospital of Eastern Ontario grossing protocol
Consolato Sergi, Mohit Kehar, Carolina Jiménez‐Rivera
Therapeutic Advances in Endocrinology and Metabolism (2024) Vol. 15
Open Access | Times Cited: 3
Metabolic dysfunction associated fatty liver disease: The new nomenclature and its impact
Si-Ying Tang, Jian Shiun Tan, Xian-Zheng Pang, et al.
World Journal of Gastroenterology (2023) Vol. 29, Iss. 3, pp. 549-560
Open Access | Times Cited: 10
MBOAT7 in liver and extrahepatic diseases
Andrea Caddeo, Rocco Spagnuolo, Samantha Maurotti
Liver International (2023) Vol. 43, Iss. 11, pp. 2351-2364
Open Access | Times Cited: 9
Relevance of PNPLA3, TM6SF2, HSD17B13, and GCKR Variants to MASLD Severity in an Egyptian Population
Nehal Elmansoury, Ahmed A. Megahed, Ahmed Kamal, et al.
Genes (2024) Vol. 15, Iss. 4, pp. 455-455
Open Access | Times Cited: 3
Associations between metabolic dysfunction-associated fatty liver disease and atherosclerotic cardiovascular disease
Wen Wen, Huahao Fan, Shenghui Zhang, et al.
The American Journal of the Medical Sciences (2024) Vol. 368, Iss. 6, pp. 557-568
Closed Access | Times Cited: 2
Simple proxies of insulin resistance identify obese metabolic dysfunction‐associated fatty liver disease subjects with advanced liver disease
Giovanni Petralli, A Salvati, Domenico Tricò, et al.
Diabetes/Metabolism Research and Reviews (2023) Vol. 40, Iss. 2
Open Access | Times Cited: 3
Recent Progresses on Pathophysiology, Diagnosis, Therapeutic Modalities, and Management of Non-alcoholic Fatty Liver Disorder
Mahdi Barazesh, Sajad Jalili, Morteza Akhzari, et al.
Current Drug Therapy (2023) Vol. 19, Iss. 1, pp. 20-48
Closed Access | Times Cited: 1
Is the Development of Ascites in Alcoholic Liver Patients Influenced by Specific KIR/HLA Gene Profiles?
Isabel Legáz, Raquel Morales, José Miguel Bolarín, et al.
Biomedicines (2023) Vol. 11, Iss. 9, pp. 2405-2405
Open Access | Times Cited: 1
Page 1

Scroll to top